1 Complete miscarriage |
8 |
1377 |
Risk Ratio (M-H, Random, 95% CI) |
0.96 [0.92, 1.00] |
1.1 Vaginal misoprostol |
3 |
154 |
Risk Ratio (M-H, Random, 95% CI) |
0.91 [0.83, 0.99] |
1.2 Oral misoprostol |
4 |
1143 |
Risk Ratio (M-H, Random, 95% CI) |
0.97 [0.93, 1.02] |
1.3 Vaginal + oral misoprostol |
1 |
80 |
Risk Ratio (M-H, Random, 95% CI) |
0.95 [0.87, 1.04] |
1.4 Rectal misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
1.5 Sublingual misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
2 Surgical evacuation |
8 |
1538 |
Risk Ratio (M-H, Random, 95% CI) |
0.07 [0.03, 0.18] |
2.1 Vaginal misoprostol |
3 |
315 |
Risk Ratio (M-H, Random, 95% CI) |
0.18 [0.08, 0.44] |
2.2 Oral misoprostol |
4 |
1143 |
Risk Ratio (M-H, Random, 95% CI) |
0.05 [0.02, 0.10] |
2.3 Vaginal + oral misoprostol |
1 |
80 |
Risk Ratio (M-H, Random, 95% CI) |
0.04 [0.01, 0.18] |
2.4 Rectal misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
2.5 Sublingual misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
3 Death or serious complication |
2 |
132 |
Risk Ratio (M-H, Random, 95% CI) |
1.0 [0.04, 22.64] |
3.1 Vaginal misoprostol |
2 |
132 |
Risk Ratio (M-H, Random, 95% CI) |
1.0 [0.04, 22.64] |
3.2 Oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
3.3 Vaginal + oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
3.4 Rectal misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
3.5 Sublingual misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
4 Unplanned surgical intervention |
6 |
1158 |
Risk Ratio (M-H, Random, 95% CI) |
6.32 [2.90, 13.77] |
4.1 Vaginal misoprostol |
3 |
315 |
Risk Ratio (M-H, Random, 95% CI) |
5.56 [1.11, 27.90] |
4.2 Oral misoprostol |
3 |
843 |
Risk Ratio (M-H, Random, 95% CI) |
6.12 [1.99, 18.84] |
4.3 Vaginal + oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
4.4 Rectal misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
4.5 Sublingual misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
5 Blood transfusion |
4 |
430 |
Risk Ratio (M-H, Random, 95% CI) |
1.73 [0.19, 16.08] |
5.1 Vaginal misoprostol |
3 |
241 |
Risk Ratio (M-H, Random, 95% CI) |
1.73 [0.19, 16.08] |
5.2 Oral misoprostol |
1 |
189 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
5.3 Vaginal + oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
5.4 Rectal misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
5.5 Sublingual misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
6 Haemorrhage |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
6.1 Vaginal misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
6.2 Oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
6.3 Vaginal + oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
6.4 Rectal misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
6.5 Sublingual misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
7 Blood loss |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
7.1 Vaginal misoprostol |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
7.2 Oral misoprostol |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
7.3 Vaginal + oral misoprostol |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
7.4 Rectal misoprostol |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
7.5 Sublingual misoprostol |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
8 Anaemia |
1 |
36 |
Risk Ratio (M-H, Random, 95% CI) |
1.71 [0.24, 12.24] |
8.1 Vaginal misoprostol |
1 |
36 |
Risk Ratio (M-H, Random, 95% CI) |
1.71 [0.24, 12.24] |
8.2 Oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
8.3 Vaginal + oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
8.4 Rectal misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
8.5 Sublingual misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
9 Days of bleeding |
3 |
211 |
Mean Difference (IV, Random, 95% CI) |
2.12 [1.18, 3.07] |
9.1 Vaginal misoprostol |
2 |
131 |
Mean Difference (IV, Random, 95% CI) |
2.76 [1.55, 3.97] |
9.2 Oral misoprostol |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
9.3 Vaginal + oral misoprostol |
1 |
80 |
Mean Difference (IV, Random, 95% CI) |
1.55 [0.58, 2.52] |
9.4 Rectal misoprostol |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
9.5 Sublingual misoprostol |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
10 Pain relief |
4 |
525 |
Risk Ratio (M-H, Random, 95% CI) |
1.48 [0.67, 3.25] |
10.1 Vaginal misoprostol |
3 |
313 |
Risk Ratio (M-H, Random, 95% CI) |
1.64 [1.05, 2.55] |
10.2 Oral misoprostol |
1 |
212 |
Risk Ratio (M-H, Random, 95% CI) |
0.85 [0.77, 0.92] |
10.3 Vaginal + oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
10.4 Rectal misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
10.5 Sublingual misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
11 Pelvic infection < 14 days |
7 |
907 |
Risk Ratio (M-H, Random, 95% CI) |
0.70 [0.25, 1.99] |
11.1 Vaginal misoprostol |
4 |
338 |
Risk Ratio (M-H, Random, 95% CI) |
1.14 [0.29, 4.44] |
11.2 Oral misoprostol |
2 |
489 |
Risk Ratio (M-H, Random, 95% CI) |
0.26 [0.03, 2.41] |
11.3 Vaginal + oral misoprostol |
1 |
80 |
Risk Ratio (M-H, Random, 95% CI) |
0.5 [0.05, 5.30] |
11.4 Rectal misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
11.5 Sublingual misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
12 Cervical damage |
1 |
189 |
Risk Ratio (M-H, Random, 95% CI) |
0.07 [0.00, 1.25] |
12.1 Vaginal misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
12.2 Oral misoprostol |
1 |
189 |
Risk Ratio (M-H, Random, 95% CI) |
0.07 [0.00, 1.25] |
12.3 Vaginal + oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
12.4 Rectal misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
12.5 Sublingual misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
13 Digestive disorders |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
13.1 Vaginal misoprostol |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
13.2 Oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
13.3 Vaginal + oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
13.4 Rectal misoprostol |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
13.5 Sublingual misoprostol |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
14 Hypertensive disorders |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
14.1 Vaginal misoprostol |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
14.2 Oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
14.3 Vaginal + oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
14.4 Rectal misoprostol |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
14.5 Sublingual misoprostol |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
15 Duration of hospital stay |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
15.1 Vaginal misoprostol |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
15.2 Oral misoprostol |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
15.3 Vaginal + oral misoprostol |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
15.4 Rectal misoprostol |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
15.5 Sublingual misoprostol |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
16 Psychological effects |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
16.1 Vaginal misoprostol |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
16.2 Oral misoprostol |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
16.3 Vaginal + oral misoprostol |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
16.4 Rectal misoprostol |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
16.5 Sublingual misoprostol |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
17 Subsequent fertility |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
17.1 Vaginal misoprostol |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
17.2 Oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
17.3 Vaginal + oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
17.4 Rectal misoprostol |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
17.5 Sublingual misoprostol |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
18 Women’s views/satisfaction |
4 |
1134 |
Risk Ratio (M-H, Random, 95% CI) |
0.99 [0.98, 1.01] |
18.1 Vaginal misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
18.2 Oral misoprostol |
4 |
1134 |
Risk Ratio (M-H, Random, 95% CI) |
0.99 [0.98, 1.01] |
18.3 Vaginal + oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
18.4 Rectal misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
18.5 Sublingual misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
19 Women’s views/satisfaction - continuous data |
2 |
131 |
Std. Mean Difference (IV, Random, 95% CI) |
1.01 [0.01, 2.00] |
19.1 Vaginal misoprostol |
2 |
131 |
Std. Mean Difference (IV, Random, 95% CI) |
1.01 [0.01, 2.00] |
19.2 Oral misoprostol |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
19.3 Vaginal + oral misoprostol |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
19.4 Rectal misoprostol |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
19.5 Sublingual misoprostol |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
20 Death |
1 |
38 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
20.1 Vaginal misoprostol |
1 |
38 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
20.2 Oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
20.3 Vaginal + oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
20.4 Rectal misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
20.5 Sublingual misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
21 Serious morbidity |
1 |
94 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
21.1 Vaginal misoprostol |
1 |
94 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
21.2 Oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
21.3 Vaginal + oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
21.4 Rectal misoprostol |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
21.5 Sublingual misoprostol |
0 |
0 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
22 Pathology of placental tissue |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
22.1 Vaginal misoprostol |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
22.2 Oral misoprostol |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
22.3 Vaginal + oral misoprostol |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
22.4 Rectal misoprostol |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
22.5 Sublingual misoprostol |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
23 Costs |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
23.1 Vaginal misoprostol |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
23.2 Oral misoprostol |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
23.3 Vaginal + oral misoprostol |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
23.4 Rectal misoprostol |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
23.5 Sublingual misoprostol |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
24 Nausea |
6 |
1115 |
Risk Ratio (M-H, Random, 95% CI) |
3.18 [1.78, 5.70] |
24.1 Vaginal misoprostol |
3 |
156 |
Risk Ratio (M-H, Random, 95% CI) |
1.46 [0.61, 3.48] |
24.2 Oral misoprostol |
3 |
959 |
Risk Ratio (M-H, Random, 95% CI) |
4.69 [2.64, 8.34] |
24.3 Vaginal + oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
24.4 Rectal misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
24.5 Sublingual misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
25 Vomiting |
5 |
1090 |
Risk Ratio (M-H, Random, 95% CI) |
2.25 [1.14, 4.43] |
25.1 Vaginal misoprostol |
2 |
131 |
Risk Ratio (M-H, Random, 95% CI) |
1.26 [0.12, 13.73] |
25.2 Oral misoprostol |
3 |
959 |
Risk Ratio (M-H, Random, 95% CI) |
2.39 [1.13, 5.02] |
25.3 Vaginal + oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
25.4 Rectal misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
25.5 Sublingual misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
26 Diarrhoea |
3 |
437 |
Risk Ratio (M-H, Random, 95% CI) |
4.25 [0.76, 23.73] |
26.1 Vaginal misoprostol |
2 |
131 |
Risk Ratio (M-H, Random, 95% CI) |
4.09 [0.51, 32.97] |
26.2 Oral misoprostol |
1 |
306 |
Risk Ratio (M-H, Random, 95% CI) |
4.63 [0.22, 95.55] |
26.3 Vaginal + oral misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
26.4 Rectal misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |
26.5 Sublingual misoprostol |
0 |
0 |
Risk Ratio (M-H, Random, 95% CI) |
0.0 [0.0, 0.0] |